Bottomiey SS. Secondary iron overload disorders. Sem Hematol 1998;35:77-86.Search in Google Scholar
Tavill AS, Bacon BR. Hemochromatosis: iron metabolism and the iron overload syndromes. In: Hepatology: a textbook of liver disease. Vol 2. ΨB. Sauders Co., 1990.Search in Google Scholar
Edwards CQ, Griffen LM,Goldgar D,et al. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988; 318: 1355-62.10.1056/NEJM1988052631821033367936Search in Google Scholar
McLaren CE, Gordeuk VR, Looker AC, et al. Prevalence of heterozygotes for hemochromatosis in the white population of the United States. Blood 1995;86:2021-7.10.1182/blood.V86.5.2021.bloodjournal8652021Search in Google Scholar
Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics 1996; 13:399-408.10.1038/ng0896-3998696333Search in Google Scholar
Martinez PA, Biron C, Blanc F, et al. Compound heterozygotes for hemochromatosis gene mutations: may they help understand the pathophysiology of the disease? Blood Cells, Molecules, and Diseases 1997;23:269-76.10.1006/bcmd.1997.01439410470Search in Google Scholar
Jouanoile AM, Gandon G, Jezequel Ę et al. Haemochromatosis and HLA-H (correspondence). Nature Genetics 1996;14:251-2.10.1038/ng1196-2518896550Search in Google Scholar
Jazwinsa .EC, Cullen LM, Busfields Ę et al. Haemochromatosis and HLA-A (correspondence). Nature Genetics 1996;14:249-51.10.1038/ng1196-2498896549Search in Google Scholar
Conrad ME, Umbreit JN. A concise review: iron absorption—the mucin-mobilferrin-integrin pathway. A competitive pathway for metal absorption. Am J Hematol 1993;42:67-73.10.1002/ajh.28304201148416300Search in Google Scholar
Lombard M, Chua E, O’Toole R Regulation of intestinal non-haem iron absorption. Gut 1997;40:435-9.10.1136/gut.40.4.43510271139176066Search in Google Scholar
Rothenberg BE, Voland JR. Beta-2 knockout mice develop parenchymal iron overload: a putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sci 1996; 93:1529-34.10.1073/pnas.93.4.1529399748643666Search in Google Scholar
Santos M, Schilham MW, Rademakers L, et al. Defective iron homeostasis in beta-2 microglobulin knockout mice recapitulates hereditary hemochromatosis in man. J Exp Med 1996;184:1975-85.10.1084/jem.184.5.197521928838920884Search in Google Scholar
Parkkila S, Waheed A, Britton RS, et al. Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci 1997;94:2534-9.10.1073/pnas.94.6.2534Search in Google Scholar
Feder JN, Tsuchihashi Z, Irrinki A, et al. The hemochromatosis founder mutation in HLA-H disrupts beta-2 microglobulin interaction and cell surface expression. J Biol Chem 1997;272:14025-8.10.1074/jbc.272.22.14025Search in Google Scholar
Waheed A, Parkkila S, Zhou XY, et al. Hereditary hemochromatosis: effects of C282Y and. H63D mutations on association with beta-2-microg?obulin, intracellular processing, and cell surface expression of the HEE protein in COS-7 cells. Proc Natl Acad Sci 1997;94:12384-9.10.1073/pnas.94.23.12384Search in Google Scholar
Zhou XY,Tomatsu S, Sly WS, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci 1998;95:2492-7.10.1073/pnas.95.5.2492Search in Google Scholar
Bothwell TH, MacPhail AP Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects. Sem Hematol 1998;35:55-71.Search in Google Scholar
Sullivan JL. Iron versus cholesterol—perspectives on the iron and heart disease debate. J Clin Epidemiol 1996;49:1345-52.10.1016/S0895-4356(96)00269-7Search in Google Scholar
Salonen JT, Nyyssonen K, Heikki K, et al. High-stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-11.10.1161/01.CIR.86.3.8031516192Search in Google Scholar
Meyers DG, Strickland D, Maloley PA, et al. Possible association of a reduction in cardiovascular events with blood donation. Heart !997;78:l88-93·Search in Google Scholar
McCord JM. Effects of positive iron status at the cellular level. Nutrition Rev 1996;54:85-8.10.1111/j.1753-4887.1996.tb03876.x8935218Search in Google Scholar
Corti M-C, Gaziano M, Hennekens CH. Iron status and risk of cardiovascular disease. Amt Epidemiol 1997;7:62-8.Search in Google Scholar
Tuomainen P-Ę Salonen R, Nyyssonen K, Salonen JT. Cohort study of relation between donating blood and risk of myocardial, infarction in 2ĉ82 men in eastern Finland. BMJ 1997;314:793-4.10.1136/bmj.314.7083.79321261769080998Search in Google Scholar
Miller M, Hutchins GM. Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease. JAMA 1994;272:231-3.10.1001/jama.1994.03520030073031Search in Google Scholar
Sempos CT, Looker AC, Gillum RĘ Makuc DM. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;330:1119-24.10.1056/NEJM1994042133016047993405Search in Google Scholar
Cartwright GE, Edwards CQ, Dravitz K, et ai. Hereditary hemochromatosis: phenotypic expression of the disease. N Engl J of Med 1979;3Ol: 1.75-9.Search in Google Scholar
Adams PC, Gregor JC, Kertesz AE, Valberg LS. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 3O-year database. Gastroenterology 1995; 109:177-88.10.1016/0016-5085(95)90283-XSearch in Google Scholar
Burke W; Thomson E, Khoury MJ, et al. Genetic testing for hereditary hemochromatosis and its implications. JAMA l998;280:172-8.10.1001/jama.280.2.1729669792Search in Google Scholar
Edwards CQ, Griffon LS, Ajoika RS, Kushner JP Screening for hemochromatosis: phenotype versus genotype. Sem Hαtnatol 1998;35:72-6.Search in Google Scholar
Levstik M, Adams PC. Eligibility and exclusion of hemochromatosis patients as voluntary blood donors. Can J Gastroenterology l998;!2:6l-3·Search in Google Scholar
31- GriπdonA. Blood collection. In: McClatchey KD, ed. Clinical laboratory medicine. Baltimore, MD: Williams & Wilkins, 1994:1687.Search in Google Scholar
National Institutes of Health. Use of neocytes decrease frequency of transfusions to reduce iron overload. JAMA 1979;242:2669-70.10.1001/jama.1979.03300240013014Search in Google Scholar
Alter HJ, Holland PV, Purcell RH, et a?. Post-transfusion hepatitis after exclusion of commercial and hepatitis B antigen positive donors. Ann Intern Med 1972:77:691-9.10.7326/0003-4819-77-5-6914628213Search in Google Scholar
Klein H, ed. Standards for blood banks and transfusion services. I7th ed. Bethesda, MD: American Association of Blood Banks, 1996.Search in Google Scholar
Williams AE,Thomson RA, Horton ĴA, Kleinman SH, Characterization of active blood donors who recently donated blood primarily to receive an HIV test. Transfusion 1995 (Suppl)35:42S.Search in Google Scholar
